Kairos Pharma Receives FDA Approval of Investigational New Drug (IND) Application for Its …

15th March 2022

Phase 1 clinical trial of KROS 201 to begin in 2022 at Cedars Sinai Medical Center. New patent covers the method of treating fibrosis and certain …